← Evidence map

ArticleMolecular cancer therapeutics2026

CerS2 Is a Druggable Target in Triple-Negative Breast Cancer.

Hissah Alatawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42012500